Asymmetric dimethylarginine as a novel independent risk factor for cardiovascular disease in hemodialysis patients

被引：0
|
作者：
Cibulka, R. [1 ]
Siroka, R. [1 ]
Rajdl, D. [1 ]
Racek, J. [1 ]
机构：
[1] Charles Univ Hosp, Inst Clin Biochem & Hematol, Plzen, Czech Republic
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)81215-8
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
TuP10515
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [21] Asymmetric dimethylarginine: a novel cardiovascular risk factor in end-stage renal disease (vol 40, pg 340, 2012)
    Alsagaff, M. Yusuf
    Thaha, M.
    Aminuddin, M.
    Yogiarto, R. M.
    Yogiantoro, M.
    Tomino, Y.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (02) : 832 - 832
  • [22] Asymmetric dimethylarginine (ADMA):: A novel risk marker in cardiovascular medicine and beyond
    Böger, RH
    ANNALS OF MEDICINE, 2006, 38 (02) : 126 - 136
  • [23] Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, acts as a novel cardiovascular risk factor
    Böger, R. H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 22 - 23
  • [24] Visceral Fat Level Is an Independent Risk Factor for Cardiovascular Mortality in Hemodialysis Patients
    Okamoto, Takayuki
    Morimoto, Satoshi
    Ikenoue, Tatsuyoshi
    Furumatsu, Yoshiyuki
    Ichihara, Atsuhiro
    AMERICAN JOURNAL OF NEPHROLOGY, 2014, 39 (02) : 122 - 129
  • [25] Asymmetric Dimethylarginine, Race, and Mortality in Hemodialysis Patients
    Drew, David A.
    Tighiouart, Hocine
    Scott, Tammy
    Kantor, Amy
    Fan, Li
    Artusi, Carlo
    Plebani, Mario
    Weiner, Daniel E.
    Sarnak, Mark J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (08): : 1426 - 1433
  • [26] Arginine/asymmetric dimethylarginine ratio and cardiovascular risk factors in patients with predialytic chronic kidney disease
    Hov, Gunhild Garmo
    Sagen, Erling
    Hatlen, Gudrun
    Bigonah, Arash
    Asberg, Arne
    Aasarod, Knut
    CLINICAL BIOCHEMISTRY, 2011, 44 (8-9) : 642 - 646
  • [27] Cardiovascular risk factors and the concentration of asymmetric dimethylarginine
    Gac, Pawel
    Poreba, Malgorzata
    Jurdziak, Marta
    Trzmielewska, Ewa
    Goclawska, Katarzyna
    Derkacz, Arkadiusz
    Mazur, Grzegorz
    Szuba, Andrzej
    Poreba, Rafal
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (01): : 63 - 70
  • [28] HYPERHOMOCYSTEINEMIA AS A RISK FACTOR FOR CARDIOVASCULAR-DISEASE IN PATIENTS UNDERGOING HEMODIALYSIS
    FRIEDMAN, JA
    DWYER, JT
    NUTRITION REVIEWS, 1995, 53 (07) : 197 - 201
  • [29] Asymmetric Dimethylarginine (ADMA) in cardiovascular and renal disease
    Alpoim, Patricia Nessralla
    Nunes Sousa, Leticia Parreiras
    Lucas Mota, Ana Paula
    Alves Rios, Danyelle Romana
    SantAna Dusse, Luci Maria
    CLINICA CHIMICA ACTA, 2015, 440 : 36 - 39
  • [30] Role of asymmetric dimethylarginine in cardiovascular disease and diabetes
    Schernthaner, Guntram
    Krzyzanowska, Katarzyna
    BIOMARKERS IN MEDICINE, 2008, 2 (04) : 317 - 320
12345